阈值方法用于[68Ga]Ga-PSMA-11 PET分子肿瘤体积量化及其对接受[177Lu]Lu-PSMA-617放射配体治疗的晚期前列腺癌患者生存预测的影响评估
回顾性纳入78例2018年1月至2020年12月接受[177Lu]Lu-PSMA-617放射性核素治疗的晚期前列腺癌患者,基于治疗前[68Ga]Ga-PSMA-11 PET图像比较5种直方图阈值法和2种局部自适应阈值法与基线方法量化的全身PSMA-TTV的相关性,并验证其对总生存的预后分层能力。不同阈值法量化的PSMA-TV与基线方法高度正相关,按中位PSMA-TV分层后低肿瘤负荷组中位生存期11.8至13.5个月、高肿瘤负荷组6.5至6.6个月,9种方法中8种显示低肿瘤负荷组生存概率显著更高。
要点
- 不同阈值法量化的全身PSMA-TV与基线方法高度正相关,其中广义直方图阈值法相关性最高(r=0.977)。
- 按中位PSMA-TV分层,低肿瘤负荷组中位生存期11.8至13.5个月,高肿瘤负荷组6.5至6.6个月。
- 9种阈值方法中8种显示低肿瘤负荷组生存概率显著更高(p<0.00625)。
核心结论
- 计算机视觉中常用的阈值方法有望用于[68Ga]Ga-PSMA-11 PET全身PSMA-TV的半自动量化。
- 所提出的算法驱动阈值策略较预设阈值更少随意性和偏倚,可能改善全身PSMA-TV作为影像生物标志物的应用。
研究设计与样本
- 回顾性纳入78例2018年1月至2020年12月接受[177Lu]Lu-PSMA-617放射性核素治疗的晚期前列腺癌患者。
- 使用治疗前[68Ga]Ga-PSMA-11 PET图像,以预先评估的专有软件半自动分析作为基线方法。
- 应用5种直方图阈值法和2种局部自适应阈值法量化分子肿瘤体积,并以总生存预后价值、与基线方法的相关性及标准化体模扫描性能进行验证。
主要发现
- 不同阈值法量化的全身PSMA-TV与基线方法高度正相关,广义直方图阈值法相关性最高(r=0.977,p<0.001),Sauvola阈值法次之(r=0.974,p<0.001)。
- Multiotsu(r=0.877,p<0.001)和Yen阈值法(r=0.878,p<0.001)相关性最低。
- 全部患者中位生存时间为9.87个月(95%CI 9.3至10.13)。
- 按中位全身PSMA-TV分层,低肿瘤负荷组中位生存期11.8至13.5个月,高肿瘤负荷组6.5至6.6个月。
- 9种阈值方法中8种显示低肿瘤负荷组生存概率显著更高(p<0.00625),包括SUVmax50(p=0.0038)、SUV≥3(p=0.0034)、Multiotsu(p=0.0015)、Yen(p=0.0015)、Niblack(p=0.001)、Sauvola(p=0.0001)、Otsu(p=0.0053)和Li阈值法(p=0.0053)。
关键数值与推荐
- 全身PSMA-TV与基线方法的相关性:广义直方图阈值法r=0.977(p<0.001),Sauvola r=0.974(p<0.001),Multiotsu r=0.877(p<0.001),Yen r=0.878(p<0.001)。
- 全部患者中位生存时间9.87个月(95%CI 9.3至10.13)。
- 按中位PSMA-TV分层:低肿瘤负荷组中位生存期11.8至13.5个月,高肿瘤负荷组6.5至6.6个月。
- 低肿瘤负荷组生存概率显著更高见于8/9种阈值方法(p<0.00625),各方法p值分别为SUVmax50 p=0.0038、SUV≥3 p=0.0034、Multiotsu p=0.0015、Yen p=0.0015、Niblack p=0.001、Sauvola p=0.0001、Otsu p=0.0053、Li p=0.0053。
临床怎么用
- 原文结论认为计算机视觉常用阈值方法有望用于全身PSMA-TV的半自动量化,算法驱动阈值策略较预设阈值更少随意性和偏倚。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to systematically evaluate the effect of thresholding algorithms used in computer vision for the quantification of prostate-specific membrane antigen positron emission tomography (PET) derived tumor volume (PSMA-TV) in patients with advanced prostate cancer. The results were validated with respect to the prognostication of overall survival in patients with advanced-stage prostate cancer. MATERIALS AND METHODS: A total of 78 patients who underwent [177Lu]Lu-PSMA-617 radionuclide therapy from January 2018 to December 2020 were retrospectively included in this study. [68Ga]Ga-PSMA-11 PET images, acquired prior to radionuclide therapy, were used for the analysis of thresholding algorithms. All PET images were first analyzed semi-automatically using a pre-evaluated, proprietary software solution as the baseline method. Subsequently, five histogram-based thresholding methods and two local adaptive thresholding methods that are well established in computer vision were applied to quantify molecular tumor volume. The resulting whole-body molecular tumor volumes were validated with respect to the prognostication of overall patient survival as well as their statistical correlation to the baseline methods and their performance on standardized phantom scans. RESULTS: The whole-body PSMA-TVs, quantified using different thresholding methods, demonstrate a high positive correlation with the baseline methods. We observed the highest correlation with generalized histogram thresholding (GHT) (Pearson r (r), p value (p): r = 0.977, p < 0.001) and Sauvola thresholding (r = 0.974, p < 0.001) and the lowest correlation with Multiotsu (r = 0.877, p < 0.001) and Yen thresholding methods (r = 0.878, p < 0.001). The median survival time of all patients was 9.87 months (95% CI [9.3 to 10.13]). Stratification by median whole-body PSMA-TV resulted in a median survival time from 11.8 to 13.5 months for the patient group with lower tumor burden and 6.5 to 6.6 months for the patient group with higher tumor burden. The patient group with lower tumor burden had significantly higher probability of survival (p < 0.00625) in eight out of nine thresholding methods (Fig. 2); those methods were SUVmax50 (p = 0.0038), SUV ≥3 (p = 0.0034), Multiotsu (p = 0.0015), Yen (p = 0.0015), Niblack (p = 0.001), Sauvola (p = 0.0001), Otsu (p = 0.0053), and Li thresholding (p = 0.0053). CONCLUSION: Thresholding methods commonly used in computer vision are promising tools for the semiautomatic quantification of whole-body PSMA-TV in [68Ga]Ga-PSMA-11-PET. The proposed algorithm-driven thresholding strategy is less arbitrary and less prone to biases than thresholding with predefined values, potentially improving the application of whole-body PSMA-TV as an imaging biomarker.
引用
- Kim M, Seifert R, Fragemann J, et al. Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859618. doi:10.1007/s00259-023-06163-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。